Literature DB >> 12176626

Can acute rejection be prevented in SPK transplantation?

George W Burke1, G Ciancio, J Figueiro, L Olson, C Gomez, A Rosen, K Suzart, J Miller.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12176626     DOI： 10.1016/s0041-1345(02)03149-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study.

Authors:  Ngan N Lam; Rachel Jeong; Robert R Quinn; Pietro Ravani; Huiling Xiao; Mara McAdams-DeMarco; David A Axelrod; Mark A Schnitzler; Jon J Snyder; Krista L Lentine
Journal:  Transplant Direct       Date:  2021-07-23

Review 2.  Interleukin 2 receptor antagonists for kidney transplant recipients.

Authors:  Angela C Webster; Lorenn P Ruster; Richard McGee; Sandra L Matheson; Gail Y Higgins; Narelle S Willis; Jeremy R Chapman; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

3.  Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.

Authors:  G Ciancio; J Sageshima; L Chen; J J Gaynor; L Hanson; L Tueros; E Montenora-Velarde; C Gomez; W Kupin; G Guerra; A Mattiazzi; A Fornoni; A Pugliese; D Roth; M Wolf; G W Burke
Journal:  Am J Transplant       Date:  2012-09-04       Impact factor: 8.086

4.  The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome.

Authors:  Mojgan Jalalzadeh; Nouraddin Mousavinasab; Said Peyrovi; Mohammad Hassan Ghadiani
Journal:  Nephrourol Mon       Date:  2015-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.